DUBLIN--(BUSINESS WIRE)--The "Drug Analysis: Aranesp" drug pipelines has been added to ResearchAndMarkets.com's offering. Aranesp (darbepoetin alfa; Amgen/Kyowa Hakko Kirin) is a recombinant human ...

This leaflet answers some common questions about Aranesp (darbepoetin alfa). It does not contain all the available information. It does not take the place of talking to your doctor, nurse or ...

Darbepoetin alfa (DA) 200 mcg every 2 weeks (Q2W) vs epoetin alfa (Epo) 40,000 U weekly (QW) in anemic patients (pts) receiving chemotherapy (ctx) ...